Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-01-03 @ 8:48 AM
Study NCT ID:
NCT03670069
Status:
TERMINATED
Last Update Posted:
2024-05-08
First Post:
2018-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-06
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-12
First Submit QC Date:
None
Study First Post Date:
2018-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-06
Last Update Post Date:
2024-05-08
Last Update Post Date Type:
ACTUAL